Drug used to reduce blood fats may cut SARS-CoV-2 infection by 70 per cent: Study
The team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active form fenofibric acid can significantly reduce SARS-COV-2 infection, that causes COVID-19, in human cells in the laboratory.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | COVID-19 | Fenofibrate | Laboratory Medicine | Pharmaceuticals | SARS | Study | Tricor | Trilipix